Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott AxSYM U.S. Presence May Give Firm Edge Over BNP Competitors

Aug 05 2002

Related Content

Roche NT-proBNP CHF Test Launch Expected By Jan. Pending FDA Approval

May 13 2002

Abbott Consent Decree Costs Escalate With Failed FDA QSR Inspection

Jun 17 2002

Biosite Triage BNP Reduces Diagnosis Uncertainty To 11%, NEJM Study Finds

Jul 22 2002

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window